We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TRVN market cap is 6.98M. The company's latest EPS is USD -2.1990 and P/E is -0.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | -438k | 0 | 6k | 3.02M | 180k |
| Operating Income | -15.76M | -9.35M | -10.12M | -6.2M | -8.83M |
| Net Income | -15.3M | -7.01M | -7.82M | -8.01M | -7.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31k | 3.07M | 567k | -418k | 3.13M |
| Operating Income | -26.58M | -29.49M | -51.93M | -56.38M | -35.29M |
| Net Income | -24.87M | -29.37M | -51.59M | -53.67M | -40.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 51.02M | 48.68M | 38.29M | 38.86M | 45.13M |
| Total Liabilities | 29.16M | 33.08M | 28.14M | 29.08M | 41.58M |
| Total Equity | 21.86M | 15.6M | 10.15M | 9.78M | 3.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.99M | 127.74M | 80.12M | 48.68M | 40.61M |
| Total Liabilities | 16.92M | 23.67M | 15.5M | 33.08M | 48.26M |
| Total Equity | 30.08M | 104.07M | 64.63M | 15.6M | -7.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.81M | -51.48M | -10.87M | -18.12M | -27.05M |
| Investing | -17.98M | 18k | N/A | -20k | -20k |
| Financing | 15.55M | 23.51M | -2k | 6.5M | 22.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.67M | -21.39M | -50.2M | -51.48M | -33.04M |
| Investing | 25.58M | 3.47M | -16k | 18k | -41k |
| Financing | -2.5M | 95.02M | 7.73M | 23.51M | 26.31M |
| Market Cap | 6.98M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 2.23 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | -0.91 |
| Dividend Yield | - |
| Shares Outstanding | 18.32M |
| Average Volume (1 week) | 407.69k |
| Average Volume (1 Month) | 390.68k |
| 52 Week Change | -43.13% |
| 52 Week High | 3.28 |
| 52 Week Low | 0.3227 |
| Spread (Intraday) | 0.16 (33.2%) |
| Company Name | Trevena Inc |
| Address |
251 little falls drive wilmington, massachusetts 19808 |
| Website | https://www.trevena.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
